These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26685653)

  • 81. Prostate cancer: Radium-223 safe in combination.
    Thoma C
    Nat Rev Urol; 2016 Oct; 13(10):563. PubMed ID: 27530262
    [No Abstract]   [Full Text] [Related]  

  • 82. Radium-223 and bone metastatic disease: still more to learn.
    Sartor O
    JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37952210
    [No Abstract]   [Full Text] [Related]  

  • 83. Acute Myeloid Leukemia After Radium-223 Therapy: Case Report.
    Varkaris A; Gunturu K; Kewalramani T; Tretter C
    Clin Genitourin Cancer; 2017 Aug; 15(4):e723-e726. PubMed ID: 28024949
    [No Abstract]   [Full Text] [Related]  

  • 84. New radiation therapy prolongs metastatic prostate cancer survival.
    McBride D
    ONS Connect; 2013 Sep; 28(3):49. PubMed ID: 24028051
    [No Abstract]   [Full Text] [Related]  

  • 85. [Cancer of the prostate. Xofigo in the hospitals].
    Perspect Infirm; 2015; 12(5):61. PubMed ID: 26730434
    [No Abstract]   [Full Text] [Related]  

  • 86. Advanced prostate cancer gets a new foe.
    Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):8. PubMed ID: 24396891
    [No Abstract]   [Full Text] [Related]  

  • 87. Treading carefully in de-escalation for bone-targeted agents - is less more, after all?
    Patrikidou A; Cathomas R
    Eur J Cancer; 2021 Jan; 142():141-142. PubMed ID: 33143995
    [No Abstract]   [Full Text] [Related]  

  • 88. [Not Available].
    Aktuelle Urol; 2022 Jun; 53(3):226-228. PubMed ID: 35671969
    [No Abstract]   [Full Text] [Related]  

  • 89. [Good risk/benefit profile of treatment with confirmed alpha emitter].
    Rev Med Suisse; 2015 Nov; 11(493):2082. PubMed ID: 26685653
    [No Abstract]   [Full Text] [Related]  

  • 90. Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.
    Shore ND
    Urology; 2015 Apr; 85(4):717-24. PubMed ID: 25681834
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Radium-223 treatment of bone metastases from castration-resistant prostate cancer].
    Mortensen J; Højgaard L
    Ugeskr Laeger; 2014 Jul; 176(30):1399-402. PubMed ID: 25292232
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prostate cancer - Therapy with radium-223.
    Brito AE; Amorim BJ; Martello M; Bernardo WM; Etchebehere E;
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1019-1023. PubMed ID: 29489974
    [No Abstract]   [Full Text] [Related]  

  • 93. [Radium dichloride-223 improves symptoms including in the daily clinic].
    Kirchner V; Papazyan JP
    Rev Med Suisse; 2015 Nov; 11(493):2083. PubMed ID: 26685654
    [No Abstract]   [Full Text] [Related]  

  • 94. Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases.
    Shirley M; McCormack PL
    Drugs; 2014 Apr; 74(5):579-86. PubMed ID: 24610703
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.